|
|
Post by sr71 on Jan 16, 2020 10:05:20 GMT -5
From Brazilian Instagram: www.picuki.com/tag/dassettepharmaAlthough the post does not explicitly state as such, one would believe that Afrezza is actually for sale at Dassette Pharma, whose philosophy is "It's good to do well". Looks like Biomm is moving with Afrezza as they stated last week! |
|
|
|
Post by rfogel on Jan 16, 2020 10:57:10 GMT -5
|
|
|
|
Post by sr71 on Jan 16, 2020 11:06:37 GMT -5
I'm confident that they will soon, since the profit margin (in dollars) for the pharma will be much greater than for any of the other insulins currently available in Brazil, according to the ANVISA pricelist. |
|
|
|
Post by matt on Jan 16, 2020 13:31:05 GMT -5
I'm confident that they will soon, since the profit margin (in dollars) for the pharma will be much greater than for any of the other insulins currently available in Brazil, according to the ANVISA pricelist. The profit margin on all drugs is regulated in Brazil; the pharmacy is allowed to make a gross profit of approximately 32% of their acquisition cost. So yes, the highest priced insulin means the highest gross profit for the pharmacy, but since the drug market in Brazil is nearly 100% self-pay (i.e. there is generally no private insurance coverage for outpatient drugs) that higher price comes out of the consumer's pocket. Lack of insurance coverage in the US has been one of the biggest issues for Afrezza penetration; Brazil will likely be the same story. |
|
|
|
Post by sr71 on Jan 16, 2020 13:52:59 GMT -5
The profit margin on all drugs is regulated in Brazil; the pharmacy is allowed to make a gross profit of approximately 32% of their acquisition cost. So yes, the highest priced insulin means the highest gross profit for the pharmacy, but since the drug market in Brazil is nearly 100% self-pay (i.e. there is generally no private insurance coverage for outpatient drugs) that higher price comes out of the consumer's pocket. Lack of insurance coverage in the US has been one of the biggest issues for Afrezza penetration; Brazil will likely be the same story. Agree 100%. But the difference in Brazil is that it's Biomm's responsibility to get the drug sold, and MNKD/Biomm was wise enough to get it priced at a level that presumably is greater than the incremental cost of production. I also think that Brazil will be a good test to see how Afrezza can do in a market there can be no "games" being played among insurance companies in cooperation with MNKD's pharma competitors. Only Afrezza's price there will be the limiting factor, assuming Biomm continues to live up to its responsibilities. |
|
|
|
Post by mnkdfann on Jan 16, 2020 14:13:33 GMT -5
From Brazilian Instagram: www.picuki.com/tag/dassettepharmaAlthough the post does not explicitly state as such, one would believe that Afrezza is actually for sale at Dassette Pharma, whose philosophy is "It's good to do well". Looks like Biomm is moving with Afrezza as they stated last week! INHALABLE INSULIN COMES TO DASSETTE PHARMA ⠀ We just received AFREZZA, fast-acting inhalation insulin. The product is indicated to improve glycemic control in adult patients with diabetes. Its main advantage is to dispense with the use of needles, bringing more comfort and quality of life. It is the first inhaled insulin approved by Anvisa in Brazil. According to the manufacturer, the product can prevent the use of up to 1000 injections per year. ✅How to use? Insulin comes in powder form and must be inhaled with the aid of an inhaler before meals. Insulin reaches the lung quickly and in less than 1 minute it is already in the bloodstream, where it works by lowering sugar levels. ⠀ ✅Who can use? Patients with type 1 and type 2 diabetes who need fast-acting insulin. Talk to your doctor to find out if the product can be used in your treatment ⠀ ✅Afrezza replaces basal (long-lasting) insulin? No. It must be used in combination with long-acting insulin. ⠀ ✅How can I find the product? It is available in three presentations: -Afrrezza 8 wm with 90 refills and 2 inhalers -Afrezza 4 wm / 8 ui with 90 refills each and 2 inhalers -Afrezza 12 wm with 90 refills and 2 inhalers ⠀ 📱Want to know more? Contact us by Whatsapp: (41) 99967-0516 |
|
|
|
Post by brotherm1 on Jan 16, 2020 14:41:33 GMT -5
”Its main advantage is to dispense with the use of needles,...”
|
|
|
|
Post by rfogel on Jan 16, 2020 16:07:10 GMT -5
Afrezza now on the site: www.diabeteservice.com.br/insulinas.htmlAppears to be on sale -- regular price for 12U box is 912 US dollars, currently priced at $621; regular price for 8U box is 606 US dollars, currently $454. |
|
